The Boston Globe

Business

Boston.com

Third Rock Ventures launches Ember Therapeutics

By Chris Reidy

 |  Globe Staff  

  December 15, 2011

Third Rock Ventures LLC, a venture capital firm with offices in Boston, announced the formation of Ember Therapeutics with a $34 million Series A financing. In a press release, Ember said it looks to leverage findings in brown-fat biology and recent breakthroughs in selective insulin sensitivity to develop treatments for metabolic diseases, including Type 2 diabetes and obesity. Ember’s interim chief executive is Louis Tartaglia, a partner at Third Rock Ventures.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help